UPM-Kymmene Corporation (UPM):企業の財務・戦略的SWOT分析

◆英語タイトル:UPM-Kymmene Corporation (UPM) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA8011659
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月12日
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィンランド
◆産業分野:紙・包装
◆販売価格オプション(消費税別)
Single UserUSD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

UPM-Kymmene Corporation (UPM) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

UPM-Kymmene Corporation (UPM) is a biofore company, which integrates the bio and forest industries. It manufactures and supplies an array of renewable and recyclable wood related products. The company focuses on biocomposites, biochemicals, energy, paper, plywood and others. Its product portfolio includes paper, energy, biofuels, pulp, self-adhesive labels, timber, label materials, plywood and wood plastic composite. UPM operates through a network of production plants, distribution units and global sales network. The company also offers low emission electricity to the Nordic market. It has presence in the major markets of North America, European and Asian countries. UPM is headquartered in Helsinki, Finland.

UPM-Kymmene Corporation Key Recent Developments

Oct 24,2017: UPM laying off about 150 workers at Blandin mill in Grand Rapids
Mar 21,2017: UPM to cut up to 108 jobs in Europe
Jun 22,2016: UPM appoints Antti Jaaskeläinen Executive Vice President of UPM Raflatac
Mar 14,2016: UPM Closes Madison Paper, Lay Off 214 Employees

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
UPM-Kymmene Corporation – Key Facts 5
UPM-Kymmene Corporation – Key Employees 6
UPM-Kymmene Corporation – Key Employee Biographies 7
UPM-Kymmene Corporation – Major Products and Services 8
UPM-Kymmene Corporation – History 10
UPM-Kymmene Corporation – Company Statement 15
UPM-Kymmene Corporation – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Section 2 – Company Analysis 18
Company Overview 18
UPM-Kymmene Corporation – Business Description 18
R&D Overview 19
UPM-Kymmene Corporation – Corporate Strategy 20
UPM-Kymmene Corporation – SWOT Analysis 21
SWOT Analysis – Overview 21
UPM-Kymmene Corporation – Strengths 21
UPM-Kymmene Corporation – Weaknesses 22
UPM-Kymmene Corporation – Opportunities 23
UPM-Kymmene Corporation – Threats 24
UPM-Kymmene Corporation – Key Competitors 25
Section 3 – Company Financial Ratios 26
Financial Ratios – Capital Market Ratios 26
Financial Ratios – Annual Ratios 27
Performance Chart 30
Financial Performance 30
Financial Ratios – Interim Ratios 31
Financial Ratios – Ratio Charts 32
UPM-Kymmene Corporation, Recent Deals Summary 33
Section 4 – Appendix 34
Methodology 34
Ratio Definitions 34
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
UPM-Kymmene Corporation, Key Facts 5
UPM-Kymmene Corporation, Key Employees 6
UPM-Kymmene Corporation, Key Employee Biographies 7
UPM-Kymmene Corporation, Major Products and Services 8
UPM-Kymmene Corporation, History 10
UPM-Kymmene Corporation, Other Locations 16
UPM-Kymmene Corporation, Subsidiaries 16
UPM-Kymmene Corporation, Key Competitors 25
UPM-Kymmene Corporation, Ratios based on current share price 26
UPM-Kymmene Corporation, Annual Ratios 27
UPM-Kymmene Corporation, Annual Ratios (Cont...1) 28
UPM-Kymmene Corporation, Annual Ratios (Cont...2) 29
UPM-Kymmene Corporation, Interim Ratios 31
UPM-Kymmene Corporation, Recent Deals Summary 33
Currency Codes 34
Capital Market Ratios 34
Equity Ratios 35
Profitability Ratios 35
Cost Ratios 36
Liquidity Ratios 36
Leverage Ratios 37
Efficiency Ratios 37

★海外企業調査レポート[UPM-Kymmene Corporation (UPM):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Scheid Vineyards Inc:企業の戦略・SWOT・財務情報
    Scheid Vineyards Inc - Strategy, SWOT and Corporate Finance Report Summary Scheid Vineyards Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Protagonist Therapeutics Inc (PTGX):製薬・医療:M&Aディール及び事業提携情報
    Summary Protagonist Therapeutics Inc (Protagonist) is a clinical-stage biopharmaceutical company that discovers and develops orally stable peptides as targeted therapies. The company through its proprietary technology platform develops structurally novel oral or injectable peptides for protein-prote …
  • Reliv International Inc (RELV):企業の財務・戦略的SWOT分析
    Summary Reliv International Inc (Reliv) is a nutrition company that develops, manufactures and markets nutritional supplements for basic nutrition, specific wellness needs, weight management and sports nutrition. The company’s products include Reliv Classic and Reliv NOW, a nutritional supplement wi …
  • China Health Group Inc (8225):企業の財務・戦略的SWOT分析
    China Health Group Inc (8225) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Safety-Kleen Inc:企業の戦略的SWOT分析
    Safety-Kleen Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Narada Power Source Co Ltd (300068):企業の財務・戦略的SWOT分析
    Summary Narada Power Source Co Ltd (Narada Power) is a battery manufacturer and distributor that markets and supplies stored energy solutions. The company's products include eos series batteries, acme series, acmeG series, GP series, TTG series, TT series, eosG series, GPG series, MP series, HRL ser …
  • Nipro Corp (8086):医療機器:M&Aディール及び事業提携情報
    Summary Nipro Corp (Nipro) manufactures, develops and markets pharmaceuticals, medical equipment and functional materials (including glass, rubber and plastic). The company’s products include renal products, interventional and anesthesiology products, injection and infusion products, cardiopulmonary …
  • Kayson Inc:企業の戦略・SWOT・財務分析
    Kayson Inc - Strategy, SWOT and Corporate Finance Report Summary Kayson Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Red Sky Energy Ltd (ROG):石油・ガス:M&Aディール及び事業提携情報
    Summary Red Sky Energy Ltd (Red Sky Energy) is an oil and gas exploration company that explores, develops, and produces oil and coal steam gas. The company’s gas projects comprise Taroom Trough Project and Clarence Moreton project. Its Clarence Moreton project operates a gas reserve position in Wall …
  • Asklepios BioPharmaceutical Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Asklepios Biopharmaceutical Inc (Asklepios Biopharmaceutical) is a drug development company that develops and markets novel protein and cellular based therapies. The company’s products include BNP-CHF, biostrophin, AskBio009, BNP-FVIII, BNP-RP, BNP-TLE, and BNP-OA. It also provides products …
  • Tengasco Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Tengasco Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Tengasco Inc (Tengasco) is an oil and gas exploration and production company that offers oil and gas development and exploration services. The company acquires, explores, produces, extracts, operates, m …
  • The Empire District Electric Co:電力:M&Aディール及び事業提携情報
    Summary The Empire District Electric Co (EDE), a subsidiary of Liberty Utilities Co, is a regulated utility that provides electricity, natural gas, and water services. The company generates, procures, transmits, distributes, and sells electricity. It generates electricity from natural gas, coal, and …
  • Ultrapar Participacoes S.A.:企業の戦略・SWOT・財務情報
    Ultrapar Participacoes S.A. - Strategy, SWOT and Corporate Finance Report Summary Ultrapar Participacoes S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Sandoz Inc-製薬・医療分野:企業M&A・提携分析
    Summary Sandoz Inc (Sandoz), a division of Novartis AG, is a generic pharmaceutical company that develops, manufactures and distributes and sells a range of prescription medicines and protein and biotechnology-based products known as biosimilars. The company also provides intermediary products inclu …
  • NanoString Technologies Inc (NSTG)-医療機器分野:企業M&A・提携分析
    Summary NanoString Technologies Inc (NanoString) is a provider of life science products and tools for translational research and molecular diagnostics. The company's products portfolio includes sprint profiler, Dx analysis system with flex, MAX analysis system, protein assays, solid tumor assays, ge …
  • Arvind Ltd:企業の戦略・SWOT・財務情報
    Arvind Ltd - Strategy, SWOT and Corporate Finance Report Summary Arvind Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Pint Pharma GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Pint Pharma GmbH (Pint Pharma), a subsidiary of Pint Pharma International SA, is a pharmaceutical company which develops, manufactures and markets originator drugs focused in rare disease, oncology and specialty pharma. The company offers wide range of products in the form of tablets, inject …
  • Advance Syntex Limited:企業の戦略的SWOT分析
    Advance Syntex Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Kuraray Co Ltd (3405):企業の財務・戦略的SWOT分析
    Kuraray Co Ltd (3405) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • OPKO Health Inc (OPK):医療機器:M&Aディール及び事業提携情報
    Summary OPKO Health Inc (OPKO) discovers, develops, manufactures and commercializes novel diagnostic technologies and pharmaceuticals. The company’s product portfolio includes point-of-care tests, laboratory developed tests (LDTs), molecular diagnostics tests, and proprietary pharmaceuticals and vac …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆